Logo Logo

Publications by Krug, U.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 8.

Journal article

Prassek, V. V.; Rothenberg-Thurley, M.; Sauerland, M. C.; Amler, S.; Görlich, D.; Herold, T.; Janke, H.; Schneider, S.; Subklewe, M.; Krug, U.; Faldum, A.; Berdel, W.; Wörmann, B.; Bräss, J.; Spiekermann, K.; Hiddemann, W.; Metzeler, K. (2017): AML patients aged >= 75 years enrolled into AMLCG trials: do genetic alterations impact clinical outcome in very old, intensively treated patients? In: Oncology Research and Treatment, Vol. 40: p. 29

Prassek, V.; Rothenberg-Thurley, M.; Sauerland, M. C.; Amler, S.; Görlich, D.; Herold, T.; Janke, H.; Schneider, S.; Subklewe, M.; Krug, U.; Faldum, A.; Berdel, W. E.; Wörmann, B.; Braess, J.; Hiddemann, W.; Spiekermann, K.; Metzeler, K. H. (2017): AML patients aged >= 75 years enrolled into AMLCG trials: do genetic alterations impact clinical outcome in very old, intensively treated patients? In: Haematologica, Vol. 102: pp. 209-210

Angenendt, L.; Bormann, E.; Braun, L.; Mikesch, J.-H.; Herold, T.; Metzeler, K.; Bohlander, S.; Görlich, D.; Arteaga, M. F.; Wörmann, B. J.; Lenz, G.; Müller-Tidow, C.; Hiddemann, W.; Spiekermann, K.; Krug, U.; Sauerland, M. C.; Berdel, W. E.; Schliemann, C. (2017): Calcitonin Receptor-like (CALCRL) expression predicts poor survival in acute myeloid leukemia. In: Oncology Research and Treatment, Vol. 40: p. 27

Prassek, V. V.; Rothenberg-Thurley, M.; Herold, T.; Amler, S.; Sauerland, M. C.; Goerlich, D.; Janke, H.; Schneider, S.; Subklewe, Marion; Krug, U.; Faldum, A.; Berdel, W. E.; Woermann, B.; Buechner, T.; Braess, J.; Hiddemann, W.; Spiekermann, K.; Metzeler, K. H. (2017): AML Patients Aged >= 75 Years Enrolled into AMLCG Trials: Do Gene Mutations Impact Clinical Outcome in Very Old, Intensively Treated Patients? In: Annals of Hematology, Vol. 96: S63-S63

Müller-Tidow, C.; Tschanter, P.; Röllig, C.; Thiede, C.; Koschmieder, A.; Stelljes, M.; Koschmieder, S.; Dugas, M.; Gerss, J.; Butterfaß-Bahloul, T.; Wagner, R.; Eveslage, M.; Thiem, U.; Krause, S. W.; Kaiser, U.; Kunzmann, V.; Steffen, B.; Noppeney, R.; Herr, W.; Baldus, C. D.; Schmitz, N.; Götze, K.; Reichle, A.; Kaufmann, M.; Neubauer, A.; Schäfer-Eckart, K.; Hänel, M.; Peceny, R.; Frickhofen, N.; Kiehl, M.; Giagounidis, A.; Görner, M.; Repp, R.; Link, H.; Kiani, A.; Naumann, R.; Brümmendorf, Th; Serve, H.; Ehninger, G.; Berdel, W. E.; Krug, U. (2016): Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia. In: Leukemia, Vol. 30, No. 3: pp. 555-561

Krug, U.; Berdel, W. E.; Gale, R. P.; Haferlach, C.; Schnittger, S.; Müller-Tidow, C.; Braess, J.; Spiekermann, K.; Staib, P.; Beelen, D.; Serve, H.; Schliemann, C.; Stelljes, M.; Balleisen, L.; Maschmeyer, G.; Grüneisen, A.; Eimermacher, H.; Giagounidis, A.; Rasche, H.; Hehlmann, R.; Lengfelder, E.; Thiel, E.; Reichle, A.; Aul, C.; Ludwig, W.-D.; Kern, W.; Haferlach, T.; Köpcke, W.; Görlich, D.; Sauerland, M. C.; Heinecke, A.; Wörmann, B. J.; Hiddemann, W.; Büchner, T. (2016): Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia. In: Leukemia, Vol. 30, No. 6: pp. 1230-1236

Pohlen, M.; Braess, J.; Thudium, J.; Schmid, C.; Kochanek, M.; Kreuzer, K.-A.; Görlich, D.; Gerth, U.; Rhode, C.; Müller-Tidow, C.; Stelljes, M.; Büchner, T.; Schlimok, G.; Hallek, M.; Waltenberger, J.; Hiddemann, W.; Berdel, W. E.; Heilmeier, B.; Krug, U. (2016): Patients with acute myeloid leukemia admitted to intensive care units: Scores predicting outcome and post-ICU survival. In: Oncology Research and Treatment, Vol. 39: p. 51

Büchner, T.; Schlenk, R. F.; Schaich, M.; Doehner, K.; Krahl, R.; Krauter, J.; Heil, G.; Krug, U.; Sauerland, M. C.; Heinecke, A.; Späth, Daniela; Kramer, M.; Scholl, S.; Berdel, W. E.; Hiddemann, Wolfgang; Hoelzer, D.; Hehlmann, R.; Hasford, Joerg; Hoffmann, V. S.; Doehner, H.; Ehninger, G.; Ganser, A.; Niederwieser, D. W.; Pfirrmann, Markus (2012): Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm‐Combined Prospective Analysis by the German AML Intergroup. In: Journal of Clinical Oncology, Vol. 30, No. 29: pp. 3604-3610

This list was generated on Tue Aug 11 00:49:55 2020 CEST.